Dexamethasone and Lower Extremity Block Duration

Analgesia Duration Clinical Trial

Clinical Trial Details — Status: Withdrawn

Administrative data

• NCT number: NCT01756586
• Other study ID #: IRB12-2198
• Status: Withdrawn
• Phase: Phase 4
• First received: December 20, 2012
• Last updated: April 6, 2016
• Start date: February 2013
• Est. completion date: December 2014

Study information

• Verified date: April 2016
• Source: University of Chicago
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Interventional

Clinical Trial Summary

Dexamethasone has shown to prolong upper extremity blocks. No one ha studied its effect on lower extremity blocks. The study would evaluate that point.

Recruitment information / eligibility

• Status: Withdrawn
• Enrollment: 0
• Est. completion date: December 2014
• Est. primary completion date: December 2014
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years to 75 Years

Eligibility

Inclusion Criteria:

1. Age 18-75

2. foot surgery

3. no contraindication to regional anesthesia

Exclusion Criteria:

1. opioid dependent

2. chronic pain condition

3. peripheral neuropathy

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

• Analgesia Duration

Intervention

Drug:
• Dexamethasone

• Bupivacaine
Control

Locations

Country	Name	City	State
United States	University of Chicago Medical Center	Chicago	Illinois

Sponsors (1)

Lead Sponsor	Collaborator
University of Chicago

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	increase in the duration of block		one year	No